Pharma giant Bayer on cannabis: No decision ‘until we fully understand market’
Monsanto pulled its Health Canada-approved pesticide from the cannabis market months ahead of a planned merger with German…
News September 12
Latest In: Finance
Weekly Deal Watch: Cannabis investing and M&A highlights (as of Sept. 7, 2018)
This is the first installment of a new weekly series from Marijuana Business Daily and Viridian Capital Advisors. Each week,…
News September 12
US marijuana company MJardin to go public in Canada via reverse takeover
Another notable U.S. marijuana company is completing a reverse takeover in Canada so it can go public north of…
News September 11
Marijuana-focused exchange-traded fund reaches CA$1 billion in assets
A cannabis-focused exchange-traded fund has reached 1 billion Canadian dollars ($760 million) in assets, partly stemming from recent…
News September 10
California cannabis tech firm Treez closes $11.5 million funding round
Treez, an ancillary cannabis tech company based in Oakland, California, raised $11.5 million to help fund its expansion. The company…
News September 10
FL cannabis lobbyist turned political candidate sees second bank account shut
A second bank has terminated the campaign account of Nikki Fried, a pro-medical marijuana Democrat who is running…
News September 7
MedMen inks CA$75M equity financing deal to expand US cannabis operations
Los Angeles-based MedMen Enterprises says it expects to raise up to 75 million Canadian dollars ($57 million) in…
News September 7
California marijuana company Canndescent closes $13 million funding round
California marijuana cultivator Canndescent announced Thursday that it has closed a $13 million Series C Convertible funding round…
News September 6
SEC sues cannabis investment fund, warns investors about MJ industry ‘scam artists’
The U.S. Securities and Exchange Commission charged a marijuana-focused investment fund with bilking investors out of more than…
News September 6
Cannabis firm Cronos inks $122 million deal to produce lab-grown cannabinoids
Canadian cannabis producer Cronos Group has tapped Boston-based Ginkgo Bioworks in a $122 million endeavor to biologically engineer…
News September 5
Latest Sponsored
